Retrospective Analyses Indicate Ozempic’s Protective Effects Against Stroke Fatality
UNIVERSITY OF WISCONSIN-MADISON AND UNIVERSITY OF TEXAS MEDICAL BRANCH IN GALVESTON, JUL 18 – Studies show Ozempic users had stroke death rates as low as 5.26%, significantly better than non-users, indicating potential protective effects of GLP-1 inhibito
- At the 22nd Annual Meeting, researchers presented on GLP-1 inhibitors, highlighting their potential to lessen stroke impact and reduce stroke risk.
- Using institutional and global datasets, investigators designed studies comparing stroke outcomes, with data sources described to assess Ozempic's impact on stroke risk and mortality.
- Analysis found 5.26% of Ozempic users died from stroke versus 21.61% of non-users, in a dataset of over 2 million patients.
- The Texas Medical Branch team found that GLP-1 inhibitors are linked to lower risks of cognitive side effects, seizures, future brain hemorrhage, and death after brain injury, and 'Matias Costa, MD' described this as a new perspective.
- Experts called for analyzing pharmacy data, and Ahmed Elbayomy, MD, emphasized that more research is certainly needed, seeing the potential protection offered by these medications.
43 Articles
43 Articles
Three studies recently presented at the 22nd Annual Meeting of the Association of Neurointerventionist Surgery (SNIS), in the United States, showed the potential of using GLP-1 inhibitors, a class of medicines such as Ozempic, Wegovy and Mounjaro, to mitigate the effects of the associated cerebral accident (AVC) and strokes. In the study, "The Impact of Semagglutida (Ozempic) on Mortality and Survival in Patients with AVC Aguido: A National and …
The long-term effects of the drug in young people are still unknown.
Miracle Molecule Stops Stroke Damage – And Could Tackle Alzheimer’s Next
A powerful new molecule, GAI-17, has shown striking results in reversing brain damage caused by stroke—even when given up to six hours after the event. Developed by researchers in Japan, the drug blocks a protein that triggers neuron death, sharply reducing paralysis and brain cell loss in mice. Even better, it caused no concerning side [...]
Retrospective analyses indicate Ozempic’s protective effects against stroke fatality
Three studies presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether using GLP-1 inhibitors could lessen the impacts of stroke and related brain injuries or reduce the risk of stroke altogether.
Weight loss drugs like Ozempic may help prevent stroke and reduce brain injury-related complications, studies show
Three studies presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether using GLP-1 inhibitors could lessen the impact of stroke and related brain injuries or reduce the risk of stroke altogether. These medications, which lower blood sugar and often cause weight loss, are commonly prescribed for type 2 diabetes and obesity and include drugs like semaglutide (Ozempic).
How do the new diabetes drugs stack up against the old for cancer pati
New diabetes drugs including Ozempic and Mounjaro are linked to similar or improved survival benefits for cancer patients compared to older diabetes drugs, according to international research. Some diabetes drugs have outperformed others in previous research on cancer patients with type 2 diabetes, so researchers tested glucagon-like peptide-1 receptor agonists (GLP-1RAs) against sodium-glucose cotransporter-2 inhibitors (SGLT2is) and dipeptidyl…
Coverage Details
Bias Distribution
- 64% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
